mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.007 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BRD-K80183349 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.01 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |